These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 27840358)

  • 1. A 44-Year-Old Man with Waldenstrom Macroglobulinemia and Bilateral Maxillary Sinusitis.
    Trianto HB; Wardhani SO
    Acta Med Indones; 2016 Jul; 48(3):221-227. PubMed ID: 27840358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in the prognosis and treatment of Waldenström macroglobulinemia. Literature overview and own experience].
    Adam Z; Pour L; Krejčí M; Ševčíková S; Pourová E; Ševčíková E; Král Z; Mayer J
    Vnitr Lek; 2016 Jan; 62(1):25-39. PubMed ID: 26967234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Waldenstrom macroglobulinemia with CD5+ expression presented as cryoglobulinemic glomerulonephropathy: a case report.
    Kim YL; Gong SJ; Hwang YH; Joo JE; Cho YU; Lee JA; Sung SA; Lee SY; Kim NY
    J Korean Med Sci; 2011 Jun; 26(6):824-8. PubMed ID: 21655071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of diffuse large B-cell lymphoma following Waldenström's macroglobulinemia with CHOP chemotherapy followed by combination therapy of CHOP with rituximab.
    Uchino K; Sameshima H; Miyamoto T; Iino T; Kato K; Henzan H; Aoki K; Nagafuji K; Gondo H; Harada M
    Intern Med; 2004 Feb; 43(2):131-4. PubMed ID: 15005256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful treatment with CHOP therapy for progressive of primary macroglobulinemia without further increase of serum IgM].
    Wakimoto N; Misumi M; Maeda T; Shimada T; Wakao D; Sato Y; Takahashi N; Sugahara Y; Yoshida K; Yagasaki F; Ito Y; Nakamura Y; Kawai N; Matsuda A; Jinnai I; Bessho M
    Rinsho Ketsueki; 2005 Jul; 46(7):536-8. PubMed ID: 16440749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complete response achieved after rituximab plus CHOP therapy in a patient with rapidly progressing Waldenstrom's macroglobulinemia].
    Ise M; Sakai C; Kumagai K
    Rinsho Ketsueki; 2009 Jan; 50(1):34-8. PubMed ID: 19225227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Waldenstrom macroglobulinemia presenting with pancreatic mass: a case report and review of literature.
    Nayak HK; Kar P; Bagchi A; Kapoor N; Kapahtia S; Sonika U; Kumar N; Kumar S
    JOP; 2013 Jan; 14(1):92-5. PubMed ID: 23306344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alkylating Agents in the Treatment of Waldenström Macroglobulinemia.
    Buske C
    Hematol Oncol Clin North Am; 2018 Oct; 32(5):821-827. PubMed ID: 30190020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of cryoglobulinemic glomerulonephritis derived from Waldenström's macroglobulinemia by rituximab-CHOP and tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation.
    Kawano N; Ikeda N; Yoshida S; Sugio Y; Yamashita K; Uezono S; Hayashi T; Hara S; Makino S; Shimoda K; Ueda A
    Int J Hematol; 2010 Sep; 92(2):391-7. PubMed ID: 20686877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Osteonecrosis developing after rituximab-containing chemotherapy for Waldenström macroglobulinemia].
    Nakamura F; Hirai R; Higo T; Togano T; Sekine R
    Rinsho Ketsueki; 2018; 59(3):305-309. PubMed ID: 29618689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: diagnostic challenges and therapeutic options: two case reports.
    Elba S; Castellino A; Soriasio R; Castellino C; Bonferroni M; Mattei D; Strola G; Drandi D; Mordini N; Foglietta M; Rapezzi D; Celeghini I; Grasso M; Giordano F; Fraternali Orcioni G; Massaia M
    J Med Case Rep; 2020 Jun; 14(1):75. PubMed ID: 32564775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bing-Neel syndrome revealing Waldenström's macroglobulinemia].
    Drouet T; Behin A; Psimaras D; Choquet S; Guillevin R; Hoang Xuan K
    Rev Neurol (Paris); 2010 Jan; 166(1):66-75. PubMed ID: 19403149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of refractory cold hemagglutinemia in MYD88 L265P mutation-negative Waldenström's macroglobulinemia with bortezomib.
    Izumi M; Tsunemine H; Suzuki Y; Tomita A; Kusumoto T; Kodaka T; Itoh K; Takahashi T
    Int J Hematol; 2015 Aug; 102(2):238-43. PubMed ID: 25794560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MALT lymphoma accompanied by elevated serum IgM levels mimicking Waldenström's macroglobulinemia].
    Izumi S; Kimura K; Takeda Y; Tsukamoto S; Yamazaki M; Mishina T; Nagai Y; Takaishi K; Nagao Y; Oshima-Hasegawa N; Mitsukawa S; Mimura N; Takeuchi M; Ohwada C; Iseki T; Ota S; Nakaseko C; Sakaida E
    Rinsho Ketsueki; 2018; 59(12):2600-2605. PubMed ID: 30626796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Waldenström Macroglobulinemia in Limited-Resource Settings.
    Riva E; Tietsche de Moraes Hungría V; Chiattone C; Martínez-Cordero H
    Hematol Oncol Clin North Am; 2023 Aug; 37(4):801-807. PubMed ID: 37258356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Follicular lymphoma complicated with myelofibrosis and macroglobulinemia at initial presentation].
    Kuroda H; Abe T; Jomen W; Yoshida M; Matsuno T; Sato M; Yamada M; Sakurai T; Fujii S; Maeda M; Fujita M; Nagashima K; Murase K; Kato J
    Rinsho Ketsueki; 2013 Nov; 54(11):2068-73. PubMed ID: 24305541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG).
    Buske C; Hoster E; Dreyling M; Eimermacher H; Wandt H; Metzner B; Fuchs R; Bittenbring J; Woermann B; Hohloch K; Hess G; Ludwig WD; Schimke J; Schmitz S; Kneba M; Reiser M; Graeven U; Klapper W; Unterhalt M; Hiddemann W;
    Leukemia; 2009 Jan; 23(1):153-61. PubMed ID: 18818699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological manifestations of Waldenström macroglobulinemia.
    Baehring JM; Hochberg EP; Raje N; Ulrickson M; Hochberg FH
    Nat Clin Pract Neurol; 2008 Oct; 4(10):547-56. PubMed ID: 18813229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia.
    Treon SP; Gertz MA; Dimopoulos M; Anagnostopoulos A; Blade J; Branagan AR; Garcia-Sanz R; Johnson S; Kimby E; Leblond V; Fermand JP; Maloney DG; Merlini G; Morel P; Morra E; Nichols G; Ocio EM; Owen R; Stone MJ
    Blood; 2006 May; 107(9):3442-6. PubMed ID: 16410453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myelopathy manifesting as macroglobulinemia].
    Woimant F; Schanen A; Bertail MA; Dupuy M; Lecoz P; Haguenau M; Pépin B
    Ann Med Interne (Paris); 1985; 136(2):121-4. PubMed ID: 3935023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.